Riskpilot← Back to searchSign inGet full accessEshopperne ApS
APSActiveCVR 35406980Møllelodden 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20131 employeeswww.os-365.dk
Revenue 2025
DKK -211K
-305% vs 2024
EBITDA margin
134.7%
-1376% vs 2024
Equity ratio
-23.1%
Financial strength
Net profit 2025
DKK -285K
-703% vs 2024
| Revenue | DKK -211K | -305% |
| EBITDA | DKK -284K | -1376% |
| Net profit | DKK -285K | -703% |
| Total assets | DKK 611K | +32% |
| Equity | DKK -141K | -198% |
| Employees | 1 | — |
Legal name
Eshopperne ApS
CVR number
35406980
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
29. juli 2013
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er at drive handel og produktion eller det, som kapitalejerne finder profitabelt eller virksomhedsfremmende.
Address
Møllelodden 4
Phone
+4560551112
Email
info@os-365.dk
Website
www.os-365.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 391 | 245 | 60 | 50 | -100 | -145 | — | — | — | — | 103 | -211 |
| Staff expenses | -15 | -0 | -93 | -169 | -61 | -38 | -15 | -56 | -65 | -0 | -122 | -73 |
| EBITDA | -37 | 40 | -33 | -119 | -161 | -183 | -292 | 14 | 29 | 42 | -19 | -284 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -37 | 40 | -33 | -119 | -161 | -183 | -292 | 14 | 29 | 42 | -19 | -284 |
| Net financials | -1 | -2 | -0 | 0 | 35 | 61 | 110 | -1 | -1 | -12 | -16 | -1 |
| Profit before tax | -37 | 38 | -33 | -119 | -126 | -122 | -182 | 13 | 28 | 30 | -36 | -285 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -37 | 38 | -33 | -119 | -126 | -122 | -182 | 13 | 28 | 30 | -36 | -285 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 136 | 286 | 401 | 448 | 474 | 575 | 395 | 376 | 402 | 500 | 464 | 611 |
| Equity | 98 | 136 | 103 | -15 | -141 | -263 | 149 | 162 | 190 | 220 | 144 | -141 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 38 | 150 | 297 | 463 | 616 | 838 | 246 | 214 | 212 | 280 | 320 | 752 |
| Total debt | 38 | 150 | 297 | 463 | 616 | 838 | 246 | 214 | 212 | 280 | 320 | 752 |
EBITDA margin
-28419000.0%
This company
15.8%
Market median
-179867189% vs market
20142025
Equity ratio
-23.1%
This company
38.2%
Market median
-160% vs market
20142025
Return on equity
-28538900.0%
This company
18.4%
Market median
-155102817% vs market
20142025
Net profit margin
-28538900.0%
This company
8.1%
Market median
-352332199% vs market
20142025
Asset turnover
-0.35×
This company
1.12×
Market median
-131% vs market
20142025
Debt / equity
5.33×
This company
0.62×
Market median
-760% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-11-01 – 2014-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AF Management | Management | 2021 | — | — |
SM Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
TF Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2013 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
FLAN HOLDING ApS | Company | 100.0% | 100.0% | 2020 |
FARMISAN ApS | Company | 20.0% | 20.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FLAN HOLDING ApS
Eshopperne ApS Board members of Eshopperne ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| André Fleron | Management | 0 companies |
| Steffen Møller | Chief Executive Officer | 0 companies |
| Tina Fleron Petersen | Chief Executive Officer | 0 companies |
| Rene Poul Nielsen | Board of Directors | 0 companies |